There have been many positives and less negatives mentioned about Matt and the Board but this biotech is a different beast to a junior miner. Things here do not show up results till much later in the story. I would like to take one of the negatives that myself to a lesser extent mentioned together with J's total abhorrence and milesy's slight bemusement as I now read and that is the timing , haste and price of the CR's done to get two phase 2's going.
Take a pause and fully comprehend. Two phase two trials , two united states fda approved trials which showed supurb phase 1 action with no side effects. Damn rare i would think.
Now I would like to take or steal a line from Matts recent orations regarding our progress so far, and the progress relative to whoever else is out there in our scene. I quote and it goes something like this , "In all my years I have never seen a product with the safety profile we have to offer" and if you thought that was good and I do but I ain't poppin' my bubbly over it, this is the line that ties the pain of 2018, the share price rising and then getting smashed because of fear, and where we may soon be folks.
'We are two and a half years ahead of our competition". Now that's what really excites me together with the upcoming news.
I probably would have preferred a 27c share price last year looking at acne alone, but we all do know we are a potential beast in the making.
BOT Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)